[HTML][HTML] Advances in antiviral drug discovery and development: Part I: Advancements in antiviral drug discovery
SK Saxena, N Mishra, R Saxena - 2009 - Future Medicine
Fusion inhibitors inhibit binding/fusion of the virus to the host cell, and thus prevent
noninfected cells from infection. They target either viral surface proteins (enfuvirtide) or cell …
noninfected cells from infection. They target either viral surface proteins (enfuvirtide) or cell …
Advances in Antiviral Drug Discovery and Development: Part I: Advancements in Antiviral Drug Discovery
SK Saxena, N Mishra, R Saxena - Future Virology, 2009 - Taylor & Francis
Fusion inhibitors inhibit binding/fusion of the virus to the host cell, and thus prevent
noninfected cells from infection. They target either viral surface proteins (enfuvirtide) or cell …
noninfected cells from infection. They target either viral surface proteins (enfuvirtide) or cell …
Advances in antiviral drug discovery and development: Part I: Advancements in antiviral drug discovery
SK Saxena, N Mishra, R Saxena - Future Virology, 2009 - search.proquest.com
Many antivirals used against HIV are highly toxic to white blood cells and cause
megaloblastic anemia, late drug toxicity with drug-induced immunosuppression …
megaloblastic anemia, late drug toxicity with drug-induced immunosuppression …
[PDF][PDF] Advances in antiviral drug discovery and development: Part I: Advancements in antiviral drug discovery
SK Saxena, N Mishra, R Saxena - trials - researchgate.net
Fusion inhibitors inhibit binding/fusion of the virus to the host cell, and thus prevent
noninfected cells from infection. They target either viral surface proteins (enfuvirtide) or cell …
noninfected cells from infection. They target either viral surface proteins (enfuvirtide) or cell …